Matches in Nanopublications for { ?s ?p "[The data from the current study provide evidence that patients with HER2-positive breast cancer have a significantly higher incidence of CNS metastasis after treatment with trastuzumab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[The data from the current study provide evidence that patients with HER2-positive breast cancer have a significantly higher incidence of CNS metastasis after treatment with trastuzumab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP379984.RAVuu8kWu40i6I-aD88D1HerfuLpP6EU3L8Zykxxr4d2U130_assertion description "[The data from the current study provide evidence that patients with HER2-positive breast cancer have a significantly higher incidence of CNS metastasis after treatment with trastuzumab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379984.RAVuu8kWu40i6I-aD88D1HerfuLpP6EU3L8Zykxxr4d2U130_provenance.
- NP888809.RAj3iSevfEzazUhfsLd20SKeTZrEF6M2mNHXeggYQocmo130_assertion description "[The data from the current study provide evidence that patients with HER2-positive breast cancer have a significantly higher incidence of CNS metastasis after treatment with trastuzumab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888809.RAj3iSevfEzazUhfsLd20SKeTZrEF6M2mNHXeggYQocmo130_provenance.
- NP888811.RAHQw6rJeEgOqj2X1fhQffc_PGa9hCXzPLVWsn28G6L58130_assertion description "[The data from the current study provide evidence that patients with HER2-positive breast cancer have a significantly higher incidence of CNS metastasis after treatment with trastuzumab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888811.RAHQw6rJeEgOqj2X1fhQffc_PGa9hCXzPLVWsn28G6L58130_provenance.
- NP888810.RA2uZG4-UGX4EodZwDPXIs8ifaFbNhGQ7dORvR69vyMgk130_assertion description "[The data from the current study provide evidence that patients with HER2-positive breast cancer have a significantly higher incidence of CNS metastasis after treatment with trastuzumab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888810.RA2uZG4-UGX4EodZwDPXIs8ifaFbNhGQ7dORvR69vyMgk130_provenance.